Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
boston blog main
boston top stories
life sciences
national blog main
8
×
clinical trials
fda
national top stories
new york blog main
san francisco blog main
cancer
ipo
national
new york top stories
san francisco top stories
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
indiana blog main
indiana top stories
investing
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
cancer drugs
cancer immunotherapy
chronic kidney disease
deals
europe top stories
What
ipo
8
×
new
8
×
million
biotech
medicines
raised
therapeutics
bio
companies
cancer
company
developing
drug
lead
life
momentum
public
raises
research
roundup
science
tests
week
activity
allogene
analysis
approvals
arrival
based
begin
biogen
biosciences
biotechs
bio’s
black
bring
brings
bubbles
cells
clamped
Language
unset
Current search:
biotech
×
new
×
ipo
×
" national blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M